|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.979
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.882
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.781
|
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
37 |
0.772
|
Human |
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.770
|
Human |
|
|
protein autoubiquitination
|
GO:0051865 |
37 |
0.753
|
Human |
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.541
|
Human |
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.451
|
Human |
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.415
|
Human |
|
|
protein k63 linked ubiquitination
|
GO:0070534 |
31 |
0.412
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.379
|
Human |
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.372
|
Human |
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.329
|
Human |
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.256
|
Human |
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.238
|
Human |
|
|
protein k48 linked ubiquitination
|
GO:0070936 |
38 |
0.238
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.209
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.196
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.193
|
Human |
|
|
response to other organism
|
GO:0051707 |
261 |
0.179
|
Human |
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.175
|
Human |
|
|
protein monoubiquitination
|
GO:0006513 |
39 |
0.171
|
Human |
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.167
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.164
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.157
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.151
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.144
|
|
|
|
viral release from host cell
|
GO:0019076 |
21 |
0.135
|
Human Mouse |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.132
|
Human |
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.124
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.113
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.113
|
Human |
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
61 |
0.113
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.108
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.106
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
81 |
0.104
|
Human |
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.101
|
Human |
|
|
maintenance of location
|
GO:0051235 |
112 |
0.101
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.098
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.095
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.094
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.092
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
79 |
0.091
|
Human |
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.091
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.088
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.085
|
Human |
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
91 |
0.080
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.079
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.076
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.076
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.072
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.071
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.069
|
Human |
|
|
response to radiation
|
GO:0009314 |
151 |
0.068
|
|
|
|
viral gene expression
|
GO:0019080 |
35 |
0.066
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.066
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.064
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.062
|
Human |
|
|
oogenesis
|
GO:0048477 |
2 |
0.062
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.062
|
Human |
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.061
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.060
|
Human |
|
|
defense response to virus
|
GO:0051607 |
71 |
0.058
|
Human |
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.058
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.057
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.057
|
|
|
|
androgen receptor signaling pathway
|
GO:0030521 |
34 |
0.055
|
Human |
|
|
protein k11 linked ubiquitination
|
GO:0070979 |
24 |
0.055
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.054
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.054
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.054
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.052
|
|
|
|
retina layer formation
|
GO:0010842 |
3 |
0.052
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.051
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.051
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.051
|
|
|
|
protein sumoylation
|
GO:0016925 |
25 |
0.051
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.050
|
Human |
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.049
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.048
|
Human |
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.047
|
Human |
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.047
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.046
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.046
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.045
|
|
|
|
viral life cycle
|
GO:0019058 |
132 |
0.044
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.044
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.044
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.043
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
17 |
0.043
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.043
|
Human |
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.043
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.042
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.042
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.042
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.042
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.042
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.041
|
Human |
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.041
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.040
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.040
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.039
|
|
|
|
glycosylation
|
GO:0070085 |
71 |
0.039
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.039
|
Human |
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.038
|
Human |
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.038
|
Human |
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.038
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.037
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.037
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
87 |
0.037
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.036
|
Human |
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.035
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.035
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.035
|
Human |
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.035
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.033
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.033
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.032
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
64 |
0.032
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.032
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.032
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.032
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.031
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
45 |
0.031
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.031
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.031
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.031
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.030
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.030
|
Human |
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
44 |
0.030
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.030
|
Human |
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.030
|
Human |
|
|
sequestering of metal ion
|
GO:0051238 |
24 |
0.030
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.030
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.029
|
Human |
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.029
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.029
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.029
|
Human |
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.029
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.028
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.028
|
|
|
|
negative regulation of sequestering of calcium ion
|
GO:0051283 |
41 |
0.028
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.028
|
Human |
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.028
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.027
|
Human |
|
|
cation transport
|
GO:0006812 |
331 |
0.027
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.027
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.027
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.027
|
Human |
|
|
multi organism metabolic process
|
GO:0044033 |
41 |
0.026
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.026
|
|
|
|
response to caffeine
|
GO:0031000 |
3 |
0.026
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.026
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.026
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.025
|
Human |
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.025
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.025
|
Human |
|
|
macromolecule glycosylation
|
GO:0043413 |
63 |
0.025
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.025
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.025
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.025
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
45 |
0.025
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.025
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.024
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.024
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.024
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.024
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.024
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.024
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.024
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.023
|
|
|
|
negative regulation of protein ubiquitination
|
GO:0031397 |
35 |
0.023
|
Human |
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.023
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.023
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.023
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.023
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.023
|
|
|
|
translation
|
GO:0006412 |
132 |
0.023
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.023
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.023
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.022
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.022
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
2 |
0.022
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.022
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.022
|
|
|
|
regulation of viral release from host cell
|
GO:1902186 |
20 |
0.022
|
Human Mouse |
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.022
|
|
|
|
entry into host
|
GO:0044409 |
25 |
0.022
|
Human |
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.022
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.022
|
Human |
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.022
|
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
51 |
0.022
|
Human |
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.022
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.022
|
|
|
|
regulation of cytokine mediated signaling pathway
|
GO:0001959 |
41 |
0.022
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.021
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
32 |
0.021
|
Human |
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.021
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.021
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
101 |
0.021
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.021
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.021
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.021
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.021
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.021
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.021
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.021
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.020
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.020
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.020
|
Human |
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.020
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.020
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
34 |
0.020
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
66 |
0.020
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
76 |
0.020
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.019
|
|
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.019
|
Human |
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.019
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.019
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.019
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.019
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.019
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.018
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.018
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.018
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.018
|
Human |
|
|
protein glycosylation
|
GO:0006486 |
62 |
0.018
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.018
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
59 |
0.018
|
|
|
|
spindle organization
|
GO:0007051 |
53 |
0.018
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.018
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.018
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
60 |
0.018
|
Human |
|
|
dna modification
|
GO:0006304 |
27 |
0.017
|
|
|
|
histone ubiquitination
|
GO:0016574 |
31 |
0.017
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.017
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.017
|
|
|
|
chromosome segregation
|
GO:0007059 |
114 |
0.017
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.017
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.017
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.017
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.017
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.017
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.017
|
Human |
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.017
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.017
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.017
|
|
|
|
regulation of sequestering of calcium ion
|
GO:0051282 |
41 |
0.017
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
45 |
0.017
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.016
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.016
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.016
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.016
|
|
|
|
viral transcription
|
GO:0019083 |
35 |
0.016
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.016
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.016
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
57 |
0.016
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.015
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
98 |
0.015
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.015
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.015
|
Human |
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.015
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.015
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.015
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.015
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
43 |
0.015
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.015
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
70 |
0.015
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.015
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.015
|
|
|
|
positive regulation of protein ubiquitination
|
GO:0031398 |
53 |
0.015
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.015
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.015
|
Human |
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
40 |
0.015
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.014
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
4 |
0.014
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.014
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.014
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.014
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.014
|
|
|
|
regulation of histone modification
|
GO:0031056 |
47 |
0.014
|
|
|
|
toll signaling pathway
|
GO:0008063 |
2 |
0.014
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.014
|
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
26 |
0.014
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
67 |
0.014
|
|
|
|
response to hyperoxia
|
GO:0055093 |
4 |
0.014
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.014
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.014
|
Human |
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.014
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.014
|
|
|
|
protein methylation
|
GO:0006479 |
74 |
0.013
|
|
|
|
regulation of phagocytosis engulfment
|
GO:0060099 |
2 |
0.013
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.013
|
|
|
|
response to nutrient
|
GO:0007584 |
20 |
0.013
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
29 |
0.013
|
|
|
|
regulation of interleukin 2 secretion
|
GO:1900040 |
2 |
0.013
|
|
|
|
methylation dependent chromatin silencing
|
GO:0006346 |
3 |
0.013
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.013
|
|
|
|
t cell activation
|
GO:0042110 |
99 |
0.013
|
|
|
|
negative regulation of protein modification by small protein conjugation or removal
|
GO:1903321 |
41 |
0.013
|
Human |
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.013
|
Human |
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.013
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.013
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.013
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.013
|
Human |
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.013
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
82 |
0.013
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.013
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.013
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.013
|
|
|
|
activation of innate immune response
|
GO:0002218 |
55 |
0.013
|
Human |
|
|
notch signaling pathway
|
GO:0007219 |
31 |
0.012
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.012
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.012
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.012
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.012
|
Human |
|
|
negative regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:2000059 |
3 |
0.012
|
Human |
|
|
negative regulation of protein transport
|
GO:0051224 |
75 |
0.012
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.012
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.012
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
48 |
0.012
|
Human |
|
|
regulation of protein acetylation
|
GO:1901983 |
25 |
0.012
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.012
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
1 |
0.012
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.012
|
|
|
|
response to testosterone
|
GO:0033574 |
1 |
0.012
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.012
|
Human |
|
|
positive regulation of chromatin modification
|
GO:1903310 |
30 |
0.012
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.012
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
48 |
0.012
|
|
|
|
regulation of translation
|
GO:0006417 |
89 |
0.011
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.011
|
|
|
|
regulation of type i interferon mediated signaling pathway
|
GO:0060338 |
9 |
0.011
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.011
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
18 |
0.011
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
1 |
0.011
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.011
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.011
|
|
|
|
protein n linked glycosylation via asparagine
|
GO:0018279 |
10 |
0.011
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.011
|
Human |
|
|
meiosis i
|
GO:0007127 |
4 |
0.011
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.011
|
|
|
|
regulation of response to cytokine stimulus
|
GO:0060759 |
46 |
0.011
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
130 |
0.011
|
|
|
|
negative regulation of immune response
|
GO:0050777 |
40 |
0.011
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.011
|
|
|
|
embryonic camera type eye morphogenesis
|
GO:0048596 |
2 |
0.011
|
|
|
|
er associated ubiquitin dependent protein catabolic process
|
GO:0030433 |
31 |
0.011
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.011
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.010
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.010
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.010
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
18 |
0.010
|
Human |
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.010
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.010
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.010
|
|